Central Institute of Mental Health
Mannheim, Germany
Treatment & access
- Treatments offeredpsilocybin
- Access routetrial
- Price informationFree within clinical trial
- Phone+49 621 1703 3163
About this provider
Central Institute of Mental Health in Mannheim is an active clinical research site currently listed as recruiting for 1 psychedelic or related trial (conditions include Depression in Adults, Major Depressive Disorder (MDD)), run with Cybin IRL Limited. Participation is free of charge; each study applies its own eligibility criteria and screening process, and enrolment is only possible while the study is recruiting.
Services & programs
Programs & studies
| Program | Kind | Status |
|---|---|---|
| A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder (NCT06793397) | Clinical trial · PHASE3 | Recruiting |
Common questions
Does participation cost anything?
No. Clinical trial treatment is free of charge; many studies also reimburse travel expenses. Participants never pay to join a legitimate trial.
How do I apply to a trial at this site?
Each study listed above links to its official registry page, which names the contact and the participating site. Start with our eligibility check, then contact the study team through the registry listing or ask your clinician to refer you.
What happens at screening?
After a pre-screening questionnaire, the site runs its own medical screening visit against the study protocol. Not passing screening is common and does not mean anything is wrong with you — criteria are deliberately strict.
Verification
- License / registryPublic trial registry (ClinicalTrials.gov / EU CTIS)
- Sourcehttps://clinicaltrials.gov/api/v2/studies
- Last verified